GL1X · GenesisL1 explorer

MolNFT v1 · #164580 · protein

Multicomponent peptide stapling as a diversity-driven tool for the development of inhibitors of protein-protein interactions

6T2D · E3 ubiquitin-protein ligase MDM2: “Multicomponent peptide stapling as a diversity-driven tool for the development of inhibitors of…”. X-ray diffraction, 1 ligand (M9E). MolNFT v1 #164580 on GenesisL1: 3D structure, binding sites and…

PDB
6T2D
Type
protein
Length
99 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
E3 ubiquitin-protein ligase MDM2; Stapled peptide GAR300-gp
EC
2.3.2.27
UniProt
Q00987
Ligands
M9E

Structure

x-ray diffraction · 2 distinct chains · 48% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AE3 ubiquitin-protein ligase MDM2 (EC 2.3.2.27)protein8544% helix, 13% strandQ00987
BStapled peptide GAR300-gpprotein1479% helix, 0% strand—

Ligands and binding sites

  • M9E · 2-(methylamino)-~{N}-[[4-[[2-(methylamino) ethanoylamino]methyl]phenyl]methyl]ethanamide · ligand · chains A, B
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

1 interface between chains.

  • A–B · 716 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 6T2D · Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.